Searchable abstracts of presentations at key conferences in endocrinology

ea0028p57 | Clinical practice/governance and case reports | SFEBES2012

DEME (Diabetes Endocrinology in Medical Education) Survey - Evaluation of Endocrinology and Diabetes teaching at a UK Medical School

Jose Biju , Bedward Julie , Davison Ian , Narendran Parth , Cooper Mark

Concerns have been raised that undergraduate medical education in Endocrinology/Diabetes (E&D) is not preparing students adequately for clinical practice. This project assessed trainer perceptions of the delivered D&E curriculum and identified areas for improvement. We surveyed E&D consultants at the 12 hospitals which accept students from our medical school using an online questionnaire. Emails were sent to 50 consultants. The response rate was 46% (23/50 recipien...

ea0070aep292 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Digital evaluation of ketosis and other diabetes emergencies (DEKODE) algorithm: Automated auditing system for diabetic ketoacidosis (DKA) management

Johnson Agnes , Thomas Lucretia , Melson Eka , Singh Chandan Joht , Ghosh Sandip , Narendran Parth , Kempegowda Punith

Background: Effective management of diabetic ketoacidosis (DKA) improves clinical outcomes. Regular auditing and performance feedback are key to achieving sustained and significant improvement in the management of DKA. One of the major limitations for maximal impact of an audit is the delay from initiation to results as the latter may not be applicable to the then current practice. In order to overcome this, we created an automated auditing system called Digital Evaluation of ...

ea0075d21 | Diabetes | EYES2021

Digital evaluation of ketosis and other diabetes emergencies (DEKODE): Automated auditing system for diabetic ketoacidosis management may help provide real-time instant feedback on performance

Zhou Dengyi , Kolesnyk Andrii , Melson Eka , Thomas Lucretia , Johnson Agnes , Ghosh Sandip , Narendran Parth , Kempegowda Punith

Introduction: Effective management of diabetic ketoacidosis (DKA) improves clinical outcomes. We created an automated auditing system, Digital evaluation of ketosis and other diabetes emergencies (DEKODE), which identifies DKA episodes based on fixed-rate intravenous insulin infusion (FRIII) prescription.Aim: We validated DEKODE for its ability to audit DKA management against manually collected data.Methods: All episodes identified...

ea0094p208 | Metabolism, Obesity and Diabetes | SFEBES2023

Screening for paediatric type 1 diabetes: a qualitative exploration of parent and stakeholder views [ELSA 1 Study]

Quinn Lauren , Randell Matthew , Litchfield Ian , Boardman Felicity , Narendran Parth , M Greenfield Sheila

Background: The EarLy Surveillance for Autoimmune diabetes (ELSA) study is screening 20,000 children in the UK aged 3-13 years for type 1 diabetes through measurement of islet autoantibodies. Screening aims to prevent diabetic ketoacidosis at clinical onset of disease, reducing mortality, and identifies the population who could benefit from prevention trials. The ELSA-1 study aimed to explore the perspectives of parents and stakeholders on the relative benefit...

ea0081p328 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

DKA registry: A step towards harmonising management of diabetes-related ketoacidosis in the United Kingdom-initial findings

Cooper Catherine , Rengarajan Lakshmi , Birchenough Amy , Sheikh Haaziq , Hebbar Meghnaa , Cuen Pan Carina Synn , De Parijat , Narendran Parth , Kempegowda Punith

Background: Diabetes-related ketoacidosis (DKA) is a common and potentially life threatening complication in people with diabetes. Despite national and international guidelines, interhospital guideline variation and mismanagement during admission are important contributory factors to increased DKA duration and length of stay.Aim: To establish a common DKA registry to identify gaps in management, assess outcomes and share best practises across centres.</p...

ea0073aep208 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Clinical and biochemical differences in diabetic ketoacidosis in people with type 1 and type 2 diabetes mellitus

Ooi Emma , Rengarajan Lakshmi , Melson Eka , Thomas Lucretia , Johnson Agnes , Zhou Dengyi , Wallett Lucy , Ghosh Sandip , Narendran Parth , Kempegowda Punith

IntroductionOnce thought to typify type 1 diabetes mellitus (T1DM), diabetic ketoacidosis (DKA) in people with type 2 diabetes mellitus (T2DM) is also now increasingly recognized. We explored the clinical and biochemical differences in DKA in the two types of diabetes.MethodsThis retrospective cohort study included all the DKA episodes from April 2014 to September 2020 at a large tertiary care centre in West ...

ea0095oc9.2 | Oral Communications 9 | BSPED2023

Screening for paediatric type 1 diabetes – A qualitative study of parents and stakeholders

Sai Manas Setti Naga , Quinn Lauren , Horgan Thomas , Dias Renuka , Garstang Joana , Shukla David , Greenfield Sheila , Richter Alex , Narendran Parth

Objective: The EarLy Surveillance for Autoimmune diabetes (ELSA) study is screening 20,000 children aged 3-13 years for type 1 diabetes through measurement of islet autoantibodies. Screening aims to prevent diabetic ketoacidosis at clinical onset of disease and identifies the population who could benefit from prevention trials. The ELSA-1 study aimed to explore the perspectives of parents and stakeholders on the relative benefits and limitations of screening i...

ea0095p96 | Diabetes 3 | BSPED2023

EarLy Surveillance for Autoimmune type 1 diabetes (ELSA) – paediatric, general population screening in the UK

Choudhary Shivam , Quinn Lauren , Stanley David , Dias Renuka , Rashid R , Garstang J , Shukla D , Greenfield Sheila , Richter Alex , Narendran Parth

Background: Children with pre-symptomatic type 1 diabetes (T1D) can be identified through testing for circulating islet autoantibodies (AAb). Identifying children at risk reduces diabetic ketoacidosis at onset and allows participation in trials aiming to delay disease onset. Teplizumab is the first immunomodulatory agent licensed in the US to delay the onset of T1D by 3 years in individuals at risk; a licensing decision is awaited in the UK. The EarLy Surveill...

ea0077p53 | Metabolism, Obesity and Diabetes | SFEBES2021

DKA registry: Creating a single data collection system for DKA in the West Midlands has helped identify best practices across hospitals

Cooper Catherine , Birchenough Amy , Rengarajan Lakshmi , Abdall-Razak Ali , Owen Megan , Yousuf Quratulain , Khan Sungeen , Pierrepont Zachary , De Parijat , Krishnasamy Senthilkumar , Narendran Parth , Kempegowda Punith

Background: There are several good practices to improve DKA management across hospitals. However, the lack of a unified system limits comparisons and learning from each other.Objectives: To establish a DKA registry to identify best practices across centres in the West Midlands.Methods: All people admitted with DKA at four hospitals in the West Midlands (named A, B, C, D for anonymity) from 1st January 2020 to 31st December 2020 wer...

ea0081rc10.6 | Rapid Communications 10: Diabetes, Obesity, Metabolism and Nutrition 3 | ECE2022

Differences in prevalence of, and precipitating factors for, diabetes related ketoacidosis in type 1 and type 2 diabetes mellitus

Zhou Dengyi , Sheikh Haaziq , Rajendran Dineshwaran , Soghal Shamanth , Yip Wai Nga Alice , Anilkumar Anjitha , Hebbar Meghnaa , Rengarajan Lakshmi , Krishnasamy Senthil , Narendran Parth

Introduction: Diabetes related ketoacidosis (DKA) is usually associated with type 1 diabetes mellitus (T1DM). However, DKA is increasingly being recognised in type 2 diabetes mellitus (T2DM). We studied the differences in prevalence and precipitating factors of DKA between T1DM and T2DM.Methods: This retrospective study included all DKA episodes from January to November 2021 in six hospitals in the West Midlands, UK. DKA was diagnosed as serum glucose&#8...